1Bortoloso E, Del PD, Gambaro G, et al. Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients[J]. Ren Fail, 2001, 23:483-493
2Yamada M, Kim S, Egashira K, et al. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor[J]. Arterioscler Thromb Vasc Biol, 2003, 23:1996-2001
3Lenz T, Haak T, Malek J, et al. Vascular endothelial growth factor in diabetic nephropathy[J]. Kidney Blood Press Res,2003, 26:338-343
4Khamaisi M, Schri JBF, De Vriese AS, et al. The emerging role of VEGF in diabetic kidney disease[J]. Nephrol Dial Transplant, 2003, 18:1427-1430
5Kuroki M, Kawakami M. Diabetic retinopathy-the mechanism of the ocular neovascularization and the development of anti-angiogenic drugs[J]. Nippon Rinsho, 1999, 57:584-589
6Senthil D, Choudhury GG, Mclaurin C, et al. Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: a potential role in diabetic nephropathy[J]. Kidney Int, 2003, 64:468-479
7Suzuki D, Miyazaki M, Jinde K, et al. In situ hybridization studies of matrix metalloproteinase-3,tissue inhibitor of metalloproteinase-1 and Ⅳ collagen in diabetic nephropathy[J]. Kidney Int, 1997, 52:111-119.
